We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

95 hedge funds and large institutions have $254M invested in Cytokinetics in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 40 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more call options, than puts

Call options by funds: $1.35M | Put options by funds: $919K

36% more capital invested

Capital invested by funds: $187M → $254M (+$66.6M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

13% less funds holding

Funds holding: 109 → 95 (-14)

40% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 40

62% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 21

Holders
95
Holders Change
-14
Holders Change %
-12.84%
% of All Funds
2.53%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
8
Increased
24
Reduced
40
Closed
21
Calls
$1.35M
Puts
$919K
Net Calls
+$433K
Net Calls Change
-$2.64M

Top Buyers

1
WA
Wasatch Advisors
Utah
+$10.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$9.75M
3
BI
BVF Inc
California
+$5.32M
4
ACA
Avoro Capital Advisors
New York
+$4.13M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.75M

Top Sellers

1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$7.3M
2
SFM
Sphera Funds Management
Israel
-$2.54M
3
EI
EAM Investors
California
-$2.16M
4
MCM
Matarin Capital Management
New York
-$1.86M
5
Invesco
Invesco
Georgia
-$1.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
TI
101
Trexquant Investment
Connecticut
– -$792K -112,403 Closed
Millennium Management
102
Millennium Management
New York
– -$718K -101,891 Closed
Two Sigma Investments
103
Two Sigma Investments
New York
– -$711K -100,824 Closed
SIM
104
Spark Investment Management
New York
– -$708K -100,500 Closed
ARTA
105
A.R.T. Advisors
New York
– -$530K -75,197 Closed
AI
106
Analytic Investors
California
– -$523K -74,206 Closed
Susquehanna International Group
107
Susquehanna International Group
Pennsylvania
– -$459K -55,960 Closed
Arrowstreet Capital
108
Arrowstreet Capital
Massachusetts
– -$253K -35,912 Closed
PC
109
Palo Capital
California
– -$122K -17,285 Closed
PP
110
Paloma Partners
Connecticut
– -$116K -16,460 Closed
Citadel Advisors
111
Citadel Advisors
Florida
– -$119K -14,551 Closed
Squarepoint
112
Squarepoint
New York
– -$93K -13,200 Closed
VKH
113
Virtu KCG Holdings
New York
– -$73K -10,382 Closed
DIA
114
Denver Investment Advisors
Colorado
– -$72K -10,203 Closed
AIM
115
Acrospire Investment Management
Illinois
– -$51K -7,178 Closed
MA
116
MUFG Americas
New York
– -$6K -910 Closed
1 2 3 4
5

CYTK Hedge Fund Activity: Q2 2016 in Review

95 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q2 2016, worth a combined $254M — up 36% from $187M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of CYTK and 8 opened new positions — a net loss of 13 holders — while 40 trimmed existing stakes and 24 added.

The largest buyer was Wasatch Advisors, adding an estimated $10.4M. The largest seller was Acadian Asset Management, cutting an estimated $7.3M.

  • 95 institutional investors held Cytokinetics (CYTK) as of Q2 2016, down from 109 in Q1 2016.
  • Funds reported $254M of Cytokinetics stock for Q2 2016, up 36% quarter-over-quarter.
  • 8 funds opened new Cytokinetics positions in Q2 2016 and 21 closed out, a net change of -13 holders.
  • The largest Cytokinetics buyer in Q2 2016 was Wasatch Advisors, an estimated $10.4M added.
  • The largest Cytokinetics seller in Q2 2016 was Acadian Asset Management, an estimated $7.3M sold.

Based on aggregated 13F filings for Q2 2016.